Basilea Pharmaceutica Calls Shareholder Meeting on HBM’s Request
Basilea Pharmaceutica (BSLN) AG will hold an extraordinary meeting of shareholders Nov. 29 on the request of HBM Bioventures AG, one of its investors, the company said in an e-mailed statement today. Shareholders will vote on a proposal to add board members.
To contact the editor responsible for this story: Thomas Mulier at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.